Inactive Instrument
CEREP Share Price Euronext Paris
Stocks
FR0004042232
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 30/04 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 02/25/02 | Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 7.72Cr 8.95Cr 7.1Cr 6.68Cr 13Cr 844.23Cr 13Cr 84Cr 33Cr 414.33Cr 34Cr 33Cr 1.43TCr | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 5.61Cr 6.51Cr 5.16Cr 4.86Cr 9.13Cr 614.12Cr 9.21Cr 61Cr 24Cr 301.4Cr 24Cr 24Cr 1.04TCr | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 11/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 11/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 23/05/2024 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.51% | -1.28% | -13.21% | -11.53% | 4.34TCr | ||
| +0.76% | +9.42% | +303.09% | +540.82% | 3.35TCr | ||
| -4.74% | -6.31% | +10.75% | -20.99% | 2.85TCr | ||
| -0.47% | -0.35% | +3.38% | +31.20% | 2.92TCr | ||
| +0.06% | +4.36% | +13.31% | +21.11% | 2.53TCr | ||
| -0.02% | +10.18% | - | - | 1.44TCr | ||
| -0.98% | -1.86% | +53.43% | +106.06% | 1.31TCr | ||
| -1.50% | -4.29% | +1.79% | +2.63% | 1.27TCr | ||
| +1.67% | +1.35% | +105.56% | +81.16% | 1.23TCr | ||
| Average | -0.82% | +1.33% | +59.76% | +93.81% | 2.36TCr | |
| Weighted average by Cap. | -1.04% | +1.35% | +62.38% | +105.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.05Cr 4.69Cr 3.72Cr 3.5Cr 6.58Cr 442.91Cr 6.64Cr 44Cr 17Cr 217.37Cr 18Cr 17Cr 751.99Cr | 4.11Cr 4.76Cr 3.78Cr 3.56Cr 6.68Cr 449.6Cr 6.74Cr 45Cr 17Cr 220.65Cr 18Cr 17Cr 763.34Cr |
| Net income | 71.55L 82.93L 65.78L 61.91L 1.16Cr 78Cr 1.17Cr 7.8Cr 3.03Cr 38Cr 3.11Cr 3.05Cr 132.88Cr | 47.82L 55.44L 43.97L 41.39L 77.77L 52Cr 78.42L 5.21Cr 2.03Cr 26Cr 2.08Cr 2.04Cr 89Cr |
| Net Debt | -1.73Cr -2Cr -1.59Cr -1.49Cr -2.81Cr -188.74Cr -2.83Cr -19Cr -7.32Cr -93Cr -7.51Cr -7.35Cr -320.44Cr | -2.1Cr -2.44Cr -1.93Cr -1.82Cr -3.42Cr -230.11Cr -3.45Cr -23Cr -8.92Cr -112.93Cr -9.15Cr -8.96Cr -390.68Cr |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















